Results 121 to 130 of about 9,306,982 (363)
Cerebral Glucose Metabolism in Parkinson’s Disease [PDF]
W. R. Wayne Martin+8 more
openalex +1 more source
: Table S1 Clinical characteristics of the study participants. Table S2 General linear models for fecal genera based on differences between patients with PD and healthy controls. (DOCX 19Â kb)
Chin-Hsien Lin+10 more
openaire +1 more source
Magnetic‐Driven Torque‐Induced Electrical Stimulation for Millisecond‐Scale Wireless Neuromodulation
MagTIES is a wireless neuromodulation technique with millisecond precision. It employs magnetic‐driven torque from magnetite nanodiscs to activate piezoelectric nanoparticles, enabling precise temporal control of neuronal activity and brain oscillations using weak, low‐frequency magnetic fields.
Chao‐Chun Cheng+5 more
wiley +1 more source
The brain renin-angiotensin system (RAS) has been related to dopaminergic degeneration, and high expression of the angiotensin II (AngII) type 1 receptor (AT1) gene is a marker of the most vulnerable neurons in humans.
Lucia Lage+4 more
doaj +1 more source
Knowledge mapping of ferroptosis in Parkinson’s disease: a bibliometric analysis: 2012–2023
BackgroundFerroptosis is a crucial pathogenic mechanism in Parkinson’s disease, offering significant potential for pharmacological intervention. Despite its importance, the number of bibliometric analyses examining the relationship between ferroptosis ...
Juanqin Li+7 more
doaj +1 more source
Supplementary Materials and Methods. (PDF 401Â kb)
Majbour, Nour+13 more
openaire +1 more source
Multifunctional Biomedical Devices with Closed‐Loop Systems for Precision Therapy
This review explores two major types of closed‐loop therapeutic systems: self‐sustained and externally triggered. It highlights recent advances in stimuli‐responsive materials, integrated bioelectronics, and data‐driven control strategies, offering insight into emerging strategies for personalized, responsive drug delivery.
Yixuan Leng, Rujie Sun
wiley +1 more source
Bromocriptine in the Management of End of Dose Deterioration in Parkinson’s Disease [PDF]
J. David Grimes+5 more
openalex +1 more source
This article summarizes significant technological advancements in materials, photonic devices, and bio‐interfaced systems, which demonstrate successful applications for impacting human healthcare via improved therapies, advanced diagnostics, and on‐skin health monitoring.
Seunghyeb Ban+5 more
wiley +1 more source